[go: up one dir, main page]

HK1111632B - 新颖甘油三酸酯还原剂 - Google Patents

新颖甘油三酸酯还原剂 Download PDF

Info

Publication number
HK1111632B
HK1111632B HK08106253.1A HK08106253A HK1111632B HK 1111632 B HK1111632 B HK 1111632B HK 08106253 A HK08106253 A HK 08106253A HK 1111632 B HK1111632 B HK 1111632B
Authority
HK
Hong Kong
Prior art keywords
hmg
coa reductase
inhibitor
pde3
reductase inhibitor
Prior art date
Application number
HK08106253.1A
Other languages
German (de)
English (en)
French (fr)
Other versions
HK1111632A1 (zh
Inventor
Toru Yokoyama
Taro Aoki
Original Assignee
Kowa Company, Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kowa Company, Ltd. filed Critical Kowa Company, Ltd.
Priority claimed from PCT/JP2006/310440 external-priority patent/WO2006132091A1/ja
Publication of HK1111632A1 publication Critical patent/HK1111632A1/zh
Publication of HK1111632B publication Critical patent/HK1111632B/zh

Links

HK08106253.1A 2005-06-08 2006-05-25 新颖甘油三酸酯还原剂 HK1111632B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US68837905P 2005-06-08 2005-06-08
US60/688,379 2005-06-08
PCT/JP2006/310440 WO2006132091A1 (ja) 2005-06-08 2006-05-25 新規なトリグリセリド低下剤

Publications (2)

Publication Number Publication Date
HK1111632A1 HK1111632A1 (zh) 2008-08-15
HK1111632B true HK1111632B (zh) 2011-07-29

Family

ID=

Similar Documents

Publication Publication Date Title
US20150272944A1 (en) Novel triglyceride reducing agent
TWI407955B (zh) 高脂血症之預防及／或治療劑
KR20030069983A (ko) 치료용 조합물
AU2007271186B2 (en) Combination of HMG-CoA reductase inhibitors with phosphodiesterase 4 inhibitors for the treatment of inflammatory pulmonary diseases
JP2007503381A (ja) メトホルミンとスタチンとの組み合わせを含む医薬組成物
AU2018298012A1 (en) Statin compositions and methods for use in treating synucleinopathies
AU2005237543B2 (en) Statins for the treatment of ocular hypertension and glaucoma
US20100204249A1 (en) Secretory phospholipase a2 (spla2) inhibitor and niacin drug compositions and methods for treating cardiovascular disease and dyslipidemia
JPWO2002030425A1 (ja) 糖尿病合併症予防・治療剤
HK1111632B (zh) 新颖甘油三酸酯还原剂
JP2005522490A (ja) Ｐｔｘ３遺伝子発現抑制方法
JP7356968B2 (ja) 心血管疾患に有用な医薬
US20080070938A1 (en) Medicinal composition for mitigating blood lipid or lowering blood homocysteine
JP2007513991A (ja) メタボリック症候群の処置のためのスタチンの使用
CN101068548B (zh) 用于减少、稳定富含脂质的斑块和/或防止富含脂质的斑块破裂的方法
WO2004096276A9 (ja) 糖取り込み能増強剤
US20050182036A1 (en) Medicinal composition containing an HMG-CoA reductase inhibitor
AU2013203070B2 (en) Combination of HMG-CoA reductase inhibitors with phosphodiesterase 4 inhibitors for the treatment of inflammatory pulmonary diseases
US20080045567A1 (en) Therapeutic Agent for Hyperlipemia and Therapeutic Agent for Diabetes
CA2494801A1 (en) Medicinal composition containing hmg-coa reductase inhibitor
HK1111356B (zh) 用於减少、稳定富含脂质的斑块和/或防止富含脂质的斑块破裂的方法